Lumida Wealth : Non-Consensus Invest Beyond the Ordinary
FSD: The Compliance Gene
Episode Notes
The Compliance Gene
This one is less about specific tickers and more about the psychology underneath how people take risk. Ram lays out a theory he's held for years: that humans carry a "compliance gene," an evolutionary trait that let Homo sapiens cooperate, enforce norms, and outcompete Neanderthals. He connects it to why people across history keep believing they live in the end times, why that anxiety shows up in investing, and why the strategies that actually make money often sit outside what programs like the CFA teach. He wraps with a story from the latest Lumida event and a conversation with a philosophy professor about Socrates.
- (00:00) Rebel Yell and introducing the compliance gene idea
- (01:00) The Apocalypse Now post: why every era believes it's the end times
- (03:00) The ego behind end-times thinking
- (04:30) Homo sapiens vs Neanderthals and the puzzle of who won
- (06:00) Social cooperation, the prisoner's dilemma, and search capacity
- (08:00) How the compliance gene got selected for
- (10:00) The instinct today: brands, tribes, and hazing rituals
- (11:30) Environmentalism and DEI as modern secular religions
- (14:00) Leading Earth Week at Columbia to test his own thesis
- (15:30) How end-times anxiety distorts investing and the wall of worry
- (17:00) What the CFA curriculum leaves out: momentum and animal spirits
- (18:30) Jeremy Grantham and the permabear mindset
- (20:00) Explorers vs enforcers, and the founders as defiance
- (22:00) Why Europe struggles to innovate
- (23:00) Gender, age, and how risk preference shifts after having kids
- (25:00) When norm enforcement turns dangerous: Cultural Revolution, Khmer Rouge
- (27:00) The Lumida event, the $25M townhouse, and the off-angle painting
- (29:00) Meeting a philosophy professor and the death of Socrates
About the show: Non-Consensus Investing is Ram Ahluwalia's running commentary on markets, where he shares how he's actually positioning capital and talks through the ideas most investors are missing. Real-time analysis, specific names, and a bias toward what's overlooked rather than what's crowded.